Fortrea Holdings Inc. (FTRE) vs Intellia Therapeutics, Inc. (NTLA)

A side-by-side comparison of Fortrea Holdings Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FTRE vs NTLA

growth of $100 · dividends reinvested · last 3y
FTRE -37.5% (-14.5%/yr)NTLA -71.9% (-34.5%/yr)FTRE compounded faster over this window
50100Start $100202420252026$63$28
FTRE NTLA

FTRE vs NTLA: by the numbers

  • •FTRE is the larger company ($1.90B vs $1.71B market cap).
  • •Both run net losses; FTRE's is the smaller (-3.18% vs -672.16% net margin).
  • •NTLA grew revenue faster over the past five years (7.31% vs 1.09% CAGR).

Metrics side by side

Valuation

MetricFTRENTLA
Forward P/E23.78N/A
P/S ratio0.7128.79
P/B ratio3.632.35
EV / EBITDA31.92N/A
FCF yield7.92%N/A

Profitability

MetricFTRENTLA
Gross margin17.11%76.47%
Operating margin0.41%-651.67%
Net margin-3.18%-672.16%
ROE-16.25%-54.96%
ROIC0.62%-54.45%

Growth (annualized)

MetricFTRENTLA
Revenue CAGR (5Y)1.09%7.31%
FCF CAGR (5Y)-12.98%N/A
Total return CAGR (5Y)N/A-38.01%

Frequently asked

Which has grown faster, FTRE or NTLA?
Over the past five years, NTLA grew revenue faster — FTRE at a 1.09% CAGR versus NTLA at 7.31%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.